Curated industry list

Overvalued Stocks in Biotechnology on NYSE

Explore Overvalued Stocks in Biotechnology on NYSE. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Armata Pharmaceuticals Inc (ARMP)
Fair Value-25.0% Downside Overvalued Analyst272.3% Upside Market Cap171.8 M P/E-0.6x Yield0.0% HealthWeak
  NYSE Featured in Overvalued Stocks
Protalix Biotherapeutics Inc (PLX)
Fair Value-17.0% Downside Fair Analyst350.8% Upside Market Cap191 M P/E12.8x Yield0.0% HealthGreat
  NYSE Featured in Overvalued Stocks High-Beta Stocks
Arcus Biosciences Inc (RCUS)
Fair Value-15.3% Downside Fair Analyst34.2% Upside Market Cap3.622 B P/E-9.4x Yield0.0% HealthFair
  NYSE Featured in Overvalued Stocks
Explore listed stocks on NYSE with company information and fair value data.